Hashish oil agency PharmaCielo to purchase Australia’s Creso Pharma for roughly $85M


Toronto-headquartered PharmaCielo agreed to buy Creso Pharma, an Australian-traded cannabis oil producer, for 122 million Australian {dollars} ($85 million).

PharmaCielo is the father or mother of PharmaCielo Colombia Holdings, a producer of medical cannabis oils in Colombia.

Creso Pharma is a medical cannabis firm specializing within the analysis, growth and manufacturing of therapeutic, nutraceutical and animal well being merchandise, primarily in Switzerland, with cultivation services in Canada, Colombia and Israel.

Its merchandise are bought in 13 nations.

Extra particulars on the acquisition, which is anticipated to shut in September, may be discovered right here.

PharmaCielo trades on the Toronto Enterprise Inventory Change underneath the ticker image PCLO.

Creso Pharma trades on the Australian Securities Change as CPH.

For extra evaluation and in-depth appears to be like on the funding traits and offers driving the cannabis trade ahead, join for our new premium subscription service, Investor Intelligence.


Latest posts